Abpro’s (ABP) Sell (E+) Rating Reiterated at Weiss Ratings

Weiss Ratings restated their sell (e+) rating on shares of Abpro (NASDAQ:ABP) in a report issued on Wednesday morning,Weiss Ratings reports.

Abpro Stock Performance

Shares of NASDAQ ABP opened at $0.18 on Wednesday. The business has a 50-day moving average of $0.23 and a 200-day moving average of $0.24. Abpro has a fifty-two week low of $0.15 and a fifty-two week high of $13.00.

Abpro (NASDAQ:ABP) last announced its quarterly earnings data on Wednesday, August 13th. The company reported ($0.04) earnings per share for the quarter.

Hedge Funds Weigh In On Abpro

A hedge fund recently raised its stake in Abpro stock. Geode Capital Management LLC grew its stake in Abpro Holdings Inc. (NASDAQ:ABP) by 127.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 196,494 shares of the company’s stock after acquiring an additional 110,159 shares during the period. Geode Capital Management LLC owned 0.32% of Abpro worth $42,000 at the end of the most recent quarter. Institutional investors and hedge funds own 23.30% of the company’s stock.

About Abpro

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.